Management
-
Dr. Yupo Ma M.D., Ph.D.
Chief Scientific Officer
Chairman of the Board and Founder
-
Greg Deener
Chief Executive Officer
-
Neil S. Levinbook, Esq.
General Counsel
-
Lisa Ma
Corporate Treasurer and Managing Director of partner company, iCAR Bio Therapeutics Ltd.
-
Mithlesh Kush
Business Development
-
Dr. Nabil Hagag, Ph.D.
VP, Regulatory Affairs and Manufacturing Manager
-
Kevin Pinz
Company Manager
-
Dr. Ahmed Abdel-Razek M.D.
Medical Director
Mr. Greg Deener
Chief Executive Officer
Mr. Deener has over 25 years of experience in the pharmaceutical industry serving in a variety of vital senior leadership positions at GSK, GTx, Sucampo, Indivior and was in Brand Management at Procter & Gamble. He has led successful global launches with leadership roles both in the US and in Europe. Mr. Deener has proficiency for early-stage commercialization/development strategy and had led teams for numerous products including extensive experience in oncology, orphan diseases and autoimmune conditions. Mr. Deener has expertise in business development and licensing having had a leadership role in delivering several agreements with leading companies. At GTx, Mr. Deener was an SEC registered officer at the time GTx went public and had an integral role in investor relations.
Dr. Ahmed Abdel-Razek, M.D.
Medical Director
As the Head of the Medical Department at Oncology, Rare Diseases, CNS, Allergy Biotechnology, I have over 15 years of experience in building and directing the headquarters clinical development, pharmacovigilance and medical for new innovative therapies. I have a Doctor of Medicine degree from Cairo University and a strong background in oncology, immunology, rare diseases, COVID-19, infectious diseases, and neurology.
I am passionate about advancing the science and improving the lives of patients with unmet medical needs. I have extensive experience in designing, authoring, and monitoring clinical trials, ensuring patient safety and regulatory compliance, managing drug safety and risk assessment, and collaborating with key opinion and thought leaders. I have also contributed to multiple publications, grants, and advisory boards, demonstrating my expertise and leadership in the field. I am driven by innovation, excellence, and teamwork, and I strive to deliver high-quality results and outcomes for my company and the medical community.